Details for Patent: 9,119,848
✉ Email this page to a colleague
Which drugs does patent 9,119,848 protect, and when does it expire?
Patent 9,119,848 protects LYBALVI and is included in one NDA.
This patent has twenty-one patent family members in seventeen countries.
Summary for Patent: 9,119,848
Title: | Morphinan derivatives for the treatment of drug overdose |
Abstract: | The instant application relates to morphinan derivatives of Formula I with sustained effectiveness in treating drug toxicity and overdose: ##STR00001## |
Inventor(s): | Silverman; Bernard (Needham, MA), Fu; Fen-Ni (Northboro, MA), Guo; Chengyun (McFarland, WI) |
Assignee: | Alkermes Pharma Ireland Limited (Dublin, IE) |
Application Number: | 12/903,462 |
Patent Claim Types: see list of patent claims | Use; Compound; |
Drugs Protected by US Patent 9,119,848
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alkermes Inc | LYBALVI | olanzapine; samidorphan l-malate | TABLET;ORAL | 213378-001 | May 28, 2021 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
Alkermes Inc | LYBALVI | olanzapine; samidorphan l-malate | TABLET;ORAL | 213378-002 | May 28, 2021 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
Alkermes Inc | LYBALVI | olanzapine; samidorphan l-malate | TABLET;ORAL | 213378-003 | May 28, 2021 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
Alkermes Inc | LYBALVI | olanzapine; samidorphan l-malate | TABLET;ORAL | 213378-004 | May 28, 2021 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,119,848
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2010326676 | ⤷ Sign Up | |||
Canada | 2782529 | ⤷ Sign Up | |||
Denmark | 2506712 | ⤷ Sign Up | |||
European Patent Office | 2506712 | ⤷ Sign Up | |||
European Patent Office | 3569234 | ⤷ Sign Up | |||
Spain | 2729679 | ⤷ Sign Up | |||
Croatia | P20191029 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |